InvestorsHub Logo
Followers 617
Posts 27445
Boards Moderated 3
Alias Born 11/16/2007

Re: None

Sunday, 01/25/2015 12:19:27 PM

Sunday, January 25, 2015 12:19:27 PM

Post# of 6599
$ISCO News, SEC filings, Business Plan, and misc:

SEC filings: http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001355790&owner=include&count=40

OTCQB: http://www.otcmarkets.com/stock/ISCO/quote

Press Releases: http://www.internationalstemcell.com/Press_Releases

Recent News: http://finance.yahoo.com/q/h?s=ISCO+Headlines

They are expecting to file an IND for Parkinson’s disease soon. The plan is to hold the trial in Australia. They expect the trial time to be cut in half with this change in venue.

Having two subsidiaries bringing in revenues to offset the need for dilution while working on therapies is an excellent thing. Plus, one or both of the subsidiaries could end up huge down the road. I really like the way they have set themselves up for future growth. As with any stock in this sector, there are still risks. I only invest that which I can afford to lose. However, they are very unusual since most don't have any revenues at this stage of development.

From the ISCO website: http://www.b2i.us/profiles/investor/fullpage.asp?BzID=1468&to=cp&Nav=0&LangID=1&s=396&ID=14259

Business Model

International Stem Cell Corporation (ISCO) operates under a novel business model for the biotechnology industry. This model comprises subsidiary business units that generate revenue from the sale of products developed from scientific discoveries made by ISCO. Not only is this model self-sustaining with the revenues used to support further scientific research and development, but it also provides practical, short-term applications of the core technologies.

Therapeutic Programs
http://www.internationalstemcell.com/Therapeutic_Programs

Lifeline Skin Care (LSC)
http://www.lifelineskincare.com/

Lifeline Cell Technology (LCT)
http://www.lifelinecelltech.com/

Intellectual Property
http://www.internationalstemcell.com/Intellectual_Property

Scientific Publications
http://www.internationalstemcell.com/Scientific_Publications

Management: http://www.internationalstemcell.com/Management

Company Address:
Corporate Headquarters
5950 Priestly Drive
Carlsbad, CA 92008
Phone: +1-760-940-6383
Fax: +1-760-476-0600

~~~~~~~~~~

A potential negative for early investors is the upcoming reverse split.


To follow KarinCA, click here then click "Follow This Member" under my photo.

Be kinder than necessary, for everyone you meet is fighting some kind of battle.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ISCO News